A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.

Vaccines against various forms of cancer prime the immune system to attack.

The newly minted Baylor College of Medicine faculty member is working to crack the mystery of triple negative breast cancer.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

The liquid biopsy, which detects cell-free tumor DNA, spotted undiagnosed cancers in some women, but had a greater number of false positives and false negatives.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

Three-dimensional polymer matrices offer researchers a new representation of the extracellular matrix that can be used to study the growth of cancer cells.

The physician, toxicologist, and expert witness drew attention to health issues caused by radiation and toxic chemicals.

Three studies show that tumor cells can behave like neurons.

Microtubules need actin to disassemble focal adhesions, allowing for cell movement.

The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.

The Purdue University nutrition researcher delves into the details of how fat tissue affects tumors.

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.

Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

The Michigan State University researcher’s lab experiences shaped her interest in the role of glucose in cancer’s spread.

A human breast cancer cell divides as it moves through surrounding blood vessel cells in vitro.

Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.

A gene responsible for the free-moving, primitive nature of fetal cells is expressed in some breast cancer cells in mice and humans.